Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation

Kiyomi O. Toyooka, Shinichi Toyooka, Anirban Maitra, Qinghua Feng, Nancy C. Kiviat, Alice Smith, John D. Minna, Raheela Ashfaq, Adi F. Gazdar

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Aberrant methylation of the promoter region has emerged as the major mechanism for silencing tumor suppressor genes. However, for some genes, such as E-cadherin (CDH1), methylation and protein expression demonstrate considerable heterogeneity, making correlations difficult. We compared methylation and protein expression status of CDH1 in 56 primary breast carcinomas using semiquantitative assays. Aberrant CDH1 methylation was studied by methylation-specific polymerase chain reaction (MSP) and semiquantitative real-time MSP assays. The Cdh1 expression was investigated by immunostaining on archival formalin-fixed sections from 34 primary carcinomas and their accompanying normal epithelium and preinvasive and metastatic lesions. Membrane-specific Cdh1 expression in the neoplastic cells was quantified by image analysis using an automated cellular imaging system and a continuous score. Aberrant promoter methylation of the CDH1 was present in 24 of 56 (43%) breast carcinomas by MSP assay. There was excellent concordance between the standard MSP assay and the real-time assay (91%, P <0.0001). The concordance between loss of Cdh1 expression and CDH1 methylation by standard MSP was 71% (P = 0.02). Furthermore, there was a strong correlation between the semiquantitative assays for methylation and protein expression (r = 0.47, P = 0.005). We conclude that promoter methylation of CDH1 significantly correlated with the Cdh1 expression level, demonstrating that epigenetic silencing is a valid pathway for silencing of tumor suppressor genes in primary breast carcinomas.

Original languageEnglish
Pages (from-to)629-634
Number of pages6
JournalAmerican Journal of Pathology
Volume161
Issue number2
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Methylation
Real-Time Polymerase Chain Reaction
Breast Neoplasms
Tumor Suppressor Genes
Proteins
Cadherins
Genetic Promoter Regions
Epigenomics
Formaldehyde
Epithelium
Carcinoma
Polymerase Chain Reaction
Membranes
Genes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Toyooka, K. O., Toyooka, S., Maitra, A., Feng, Q., Kiviat, N. C., Smith, A., ... Gazdar, A. F. (2002). Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation. American Journal of Pathology, 161(2), 629-634.

Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation. / Toyooka, Kiyomi O.; Toyooka, Shinichi; Maitra, Anirban; Feng, Qinghua; Kiviat, Nancy C.; Smith, Alice; Minna, John D.; Ashfaq, Raheela; Gazdar, Adi F.

In: American Journal of Pathology, Vol. 161, No. 2, 2002, p. 629-634.

Research output: Contribution to journalArticle

Toyooka, KO, Toyooka, S, Maitra, A, Feng, Q, Kiviat, NC, Smith, A, Minna, JD, Ashfaq, R & Gazdar, AF 2002, 'Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation', American Journal of Pathology, vol. 161, no. 2, pp. 629-634.
Toyooka, Kiyomi O. ; Toyooka, Shinichi ; Maitra, Anirban ; Feng, Qinghua ; Kiviat, Nancy C. ; Smith, Alice ; Minna, John D. ; Ashfaq, Raheela ; Gazdar, Adi F. / Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation. In: American Journal of Pathology. 2002 ; Vol. 161, No. 2. pp. 629-634.
@article{926ab53500cf4ca6aae8853e3bc60bae,
title = "Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation",
abstract = "Aberrant methylation of the promoter region has emerged as the major mechanism for silencing tumor suppressor genes. However, for some genes, such as E-cadherin (CDH1), methylation and protein expression demonstrate considerable heterogeneity, making correlations difficult. We compared methylation and protein expression status of CDH1 in 56 primary breast carcinomas using semiquantitative assays. Aberrant CDH1 methylation was studied by methylation-specific polymerase chain reaction (MSP) and semiquantitative real-time MSP assays. The Cdh1 expression was investigated by immunostaining on archival formalin-fixed sections from 34 primary carcinomas and their accompanying normal epithelium and preinvasive and metastatic lesions. Membrane-specific Cdh1 expression in the neoplastic cells was quantified by image analysis using an automated cellular imaging system and a continuous score. Aberrant promoter methylation of the CDH1 was present in 24 of 56 (43{\%}) breast carcinomas by MSP assay. There was excellent concordance between the standard MSP assay and the real-time assay (91{\%}, P <0.0001). The concordance between loss of Cdh1 expression and CDH1 methylation by standard MSP was 71{\%} (P = 0.02). Furthermore, there was a strong correlation between the semiquantitative assays for methylation and protein expression (r = 0.47, P = 0.005). We conclude that promoter methylation of CDH1 significantly correlated with the Cdh1 expression level, demonstrating that epigenetic silencing is a valid pathway for silencing of tumor suppressor genes in primary breast carcinomas.",
author = "Toyooka, {Kiyomi O.} and Shinichi Toyooka and Anirban Maitra and Qinghua Feng and Kiviat, {Nancy C.} and Alice Smith and Minna, {John D.} and Raheela Ashfaq and Gazdar, {Adi F.}",
year = "2002",
language = "English",
volume = "161",
pages = "629--634",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation

AU - Toyooka, Kiyomi O.

AU - Toyooka, Shinichi

AU - Maitra, Anirban

AU - Feng, Qinghua

AU - Kiviat, Nancy C.

AU - Smith, Alice

AU - Minna, John D.

AU - Ashfaq, Raheela

AU - Gazdar, Adi F.

PY - 2002

Y1 - 2002

N2 - Aberrant methylation of the promoter region has emerged as the major mechanism for silencing tumor suppressor genes. However, for some genes, such as E-cadherin (CDH1), methylation and protein expression demonstrate considerable heterogeneity, making correlations difficult. We compared methylation and protein expression status of CDH1 in 56 primary breast carcinomas using semiquantitative assays. Aberrant CDH1 methylation was studied by methylation-specific polymerase chain reaction (MSP) and semiquantitative real-time MSP assays. The Cdh1 expression was investigated by immunostaining on archival formalin-fixed sections from 34 primary carcinomas and their accompanying normal epithelium and preinvasive and metastatic lesions. Membrane-specific Cdh1 expression in the neoplastic cells was quantified by image analysis using an automated cellular imaging system and a continuous score. Aberrant promoter methylation of the CDH1 was present in 24 of 56 (43%) breast carcinomas by MSP assay. There was excellent concordance between the standard MSP assay and the real-time assay (91%, P <0.0001). The concordance between loss of Cdh1 expression and CDH1 methylation by standard MSP was 71% (P = 0.02). Furthermore, there was a strong correlation between the semiquantitative assays for methylation and protein expression (r = 0.47, P = 0.005). We conclude that promoter methylation of CDH1 significantly correlated with the Cdh1 expression level, demonstrating that epigenetic silencing is a valid pathway for silencing of tumor suppressor genes in primary breast carcinomas.

AB - Aberrant methylation of the promoter region has emerged as the major mechanism for silencing tumor suppressor genes. However, for some genes, such as E-cadherin (CDH1), methylation and protein expression demonstrate considerable heterogeneity, making correlations difficult. We compared methylation and protein expression status of CDH1 in 56 primary breast carcinomas using semiquantitative assays. Aberrant CDH1 methylation was studied by methylation-specific polymerase chain reaction (MSP) and semiquantitative real-time MSP assays. The Cdh1 expression was investigated by immunostaining on archival formalin-fixed sections from 34 primary carcinomas and their accompanying normal epithelium and preinvasive and metastatic lesions. Membrane-specific Cdh1 expression in the neoplastic cells was quantified by image analysis using an automated cellular imaging system and a continuous score. Aberrant promoter methylation of the CDH1 was present in 24 of 56 (43%) breast carcinomas by MSP assay. There was excellent concordance between the standard MSP assay and the real-time assay (91%, P <0.0001). The concordance between loss of Cdh1 expression and CDH1 methylation by standard MSP was 71% (P = 0.02). Furthermore, there was a strong correlation between the semiquantitative assays for methylation and protein expression (r = 0.47, P = 0.005). We conclude that promoter methylation of CDH1 significantly correlated with the Cdh1 expression level, demonstrating that epigenetic silencing is a valid pathway for silencing of tumor suppressor genes in primary breast carcinomas.

UR - http://www.scopus.com/inward/record.url?scp=0036965997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036965997&partnerID=8YFLogxK

M3 - Article

VL - 161

SP - 629

EP - 634

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 2

ER -